All In Biotech

Drug Trial Radar · NCT02147899

A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis

A Phase 2, Multi-center, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effectiveness and Safety of SYM-1219 for the Treatment of Women With Bacterial Vaginosis

Last checked: Nov 20, 2026Latest source record: Nov 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 215 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

215

Actual

Start

May 2014

Primary completion

Oct 2014

Study completion Oct 2014

Sponsor

Lead sponsor
Symbiomix TherapeuticsIndustry
Sponsor type
Industry
First posted
May 28, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to test the safety and effectiveness of the oral investigational new drug, SYM-1219, for the treatment of bacterial vaginosis.

Conditions

  • Bacterial Vaginosis

Interventions

  • SYM-1219Drug

    Oral

  • PlaceboDrug

    Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cure of Bacterial VaginosisTime frame: Study Days 21-30

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Women's Health Care Research Corp.

    San Diego, California

  • Women's Medical Research Group, LLC

    Clearwater, Florida

  • Healthcare Clinical Data, Inc.

    North Miami, Florida

  • Atlanta North Gynecology, P.C

    Roswell, Georgia

  • Wayne State University

    Detroit, Michigan

  • Saginaw Valley Medical Research Group, LLC

    Saginaw, Michigan

  • Lawrence OB-GYN Clinical Research, LLC

    Lawrenceville, New Jersey

  • Scott Eder MD

    Plainsboro, New Jersey

  • Eastern Carolina Women's Center

    New Bern, North Carolina

  • Clinical Research of Philadelphia, LLC

    Philadelphia, Pennsylvania

  • The Jackson Clinic, PA

    Jackson, Tennessee

  • TMC Life Research, Inc.

    Houston, Texas

  • Clinical Trials of Texas, Inc.

    San Antonio, Texas

  • Tidewater Physicians for Women

    Virginia Beach, Virginia

  • University of Washington, Harborview Medical Center

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.